Physician profile
Howard J Balbi
NPI 1942201900
$3,895.43
in general payments reported to CMS, 2019-2025
51 companies · $1,150 in 2025
The $1,150 reported for 2025 was more than what a typical Pediatric Infectious Diseases provider received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $179 · 2021: $184 · 2022: $275 · 2023: $1,016 · 2024: $865 · 2025: $1,150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,030.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $279.41 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $270.38 | 2022-2025 | Qelbree, Qelbree |
| Biomarin Pharmaceutical INC. | $259.50 | 2019-2025 | Voxzogo 1.2mg, Brineura |
| Collegium Pharmaceutical, INC. | $189.54 | 2025 | Jornay Pm |
| Neurelis, INC. | $187.54 | 2020-2025 | Valtoco |
| Genzyme Corporation | $184.51 | 2021-2023 | |
| Ucb, INC. | $176.84 | 2022-2025 | Briviact, Fintepla, Nayzilam |
| Abbvie INC. | $166.56 | 2023-2025 | Lupron Depot |
| Ironshore Pharmaceuticals INC. | $154.60 | 2023-2024 | Jornay Pm |
| Acadia Pharmaceuticals INC | $145.59 | 2023-2025 | Daybue |
| Baxter Healthcare | $133.63 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Alexion Pharmaceuticals, INC. | $124.29 | 2023-2025 | Strensiq, Koselugo, Ultomiris |
| Novo Nordisk INC | $113.02 | 2019-2025 | Sogroya, Rivfloza |
| Takeda Pharmaceuticals U.S.A., INC. | $109.95 | 2021-2025 | Eohilia |
| Xeris Pharmaceuticals, INC. | $102.25 | 2021-2023 | Gvoke Hypopen |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Balbi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.